NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Peroxisome Proliferator Activated Receptor Gamma Agonists


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
New cerebral hemorrhage study findings reported from University of Texas, Medical Department
2009 APR 6 -- "No effective therapy is available for treating intracerebral hemorrhage (ICH). One of several key components of brain damage after ICH is the neurotoxicity of blood products," scientists writing in the journal Stroke report.   ......
Subject: Cerebral Hemorrhage
Price: $3.00
*
New findings from University of Texas, M. D. Anderson Cancer Center describe advances in cancer therapy
2009 FEB 9 -- Scientists discuss in 'Peroxisome proliferator-activated receptor gamma agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activity' new findings......
Subject: Cancer Therapy
Price: $3.00
*
Research results from W. Chearwae and colleagues update understanding of glioblastoma
2009 FEB 2 -- According to a study from the United States, "Brain tumour stem cells (BTSCs) are a small population of cells that has self-renewal, transplantation, multidrug resistance and recurrence properties, thus remain novel therapeutic target for......
Subject: Glioblastoma
Price: $3.00
*
Researchers from University of Hong Kong provide details of new studies and findings in the area of angiotensins
2009 AUG 10 -- "Human proximal tubular epithelial cells (PTEC) were pre-treated with increasing concentration of a PPAR-gamma agonist rosiglitazone or troglitazone (0-5 mc M) followed by further incubation with the conditioned medium (IgA-HMC) collected from......
Subject: Angiotensins
Price: $3.00
*
Studies from A. Bernardo and colleagues reveal new findings on central nervous system disease
2009 SEP 7 -- According to recent research from Rome, Italy, "Several lines of evidence suggest that peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists may control brain inflammation and, therefore, may be useful for the treatment of human......
Subject: Central Nervous System Disease
Price: $3.00
*
Studies from C.H. Lin et al have provided new data on medicinal chemistry
2009 JUN 23 -- According to a study from Taiwan, "Utilizing medicinal chemistry design strategies Such as benzo splitting and ring expansion, we converted PPAR alpha/gamma dual agonist 1 to selective PPAR gamma agonists 19 and 20."    "Compounds......
Subject: Medicinal Chemistry
Price: $3.00
*
Studies from R.A. Ghani et al have provided new data on kidney failure
2009 APR 20 -- "Drug-induced acute interstitial nephritis is a well-recognised and important reversible cause of acute renal failure. Peroxisome-proliferator activated receptor-gamma agonists, such as rosiglitazone, have been proven to be safe in chronic......
Subject: Kidney Failure
Price: $3.00
*
Studies from University of Pisa, Medical Department add new findings in the area of Graves disease
2009 JUN 23 -- "CXC alpha-chemokine CXCL10/IP-10 plays an important role in the initial phases of Graves' ophthalmopathy (GO). Human thyrocytes, orbital fibroblasts, and preadipocytes are stimulated to produce CXCL10 when treated with interferon gamma(IFN......
Subject: Graves Disease
Price: $3.00
*
Study data from Boston University, Medical Department provide new insights into life sciences
2009 OCT 12 -- According to recent research from the United States, "White adipose tissue (WAT) stores energy in the form of triglycerides, whereas brown tissue (BAT) expends energy, primarily by oxidizing lipids. WAT also secretes many cytokines and......
Subject: Life Sciences
Price: $3.00
*
Study results from University of Toronto in the area of falciparum malaria published
2009 OCT 5 -- According to recent research from Toronto, Canada, "Despite the use of potent antimalarial drugs, the fatality rate associated with severe malaria remains high. Adjunctive therapies that target the immunopathological responses to infection may......
Subject: Falciparum Malaria
Price: $3.00
*
New life sciences study findings recently were reported by researchers at University of Athens
2008 DEC 1 -- According to recent research published in the journal Chemical Biology & Drug Design, "Peroxisome proliferator-activated receptor-gamma offers a molecular target for drugs aimed to treat type II diabetes mellitus, while its therapeutic potency......
Subject: Life Sciences
Price: $3.00
*
Reports summarize life sciences research from National Cancer Center
2008 JUL 14 -- Researchers detail in 'Regulation of TLR2 expression by prostaglandins in brain glia,' new data in life sciences. According to a study from Korea, "TLR have emerged as important primary sensors for diverse stimuli and are increasingly......
Subject: Life Sciences
Price: $3.00
*
Research reports from Y. Jung and co-authors provide new insights into life sciences
2008 JUN 9 ... Fresh data on life sciences are presented in the report 'Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially ...
Subject: Life Sciences
Price: $3.00
*
Researchers at University of Michigan, Department of Internal Medicine have published new data on life sciences
2008 MAR 17 -- Fresh data on life sciences are presented in the report 'Immunomodulatory role of PPAR-gamma in alveolar macrophages.' "The lung is constantly exposed to inhaled pathogens and toxins yet totally dependent on the integrity of a delicate......
Subject: Life Sciences
Price: $3.00
*
Researchers from Bristol-Myers Squibb Company provide details of new studies and findings in the area of pharmacogenetics
2008 DEC 1 -- " Peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists can cause peripheral edema in susceptible individuals. To investigate the mechanistic basis underlying this adverse event we performed a candidate gene analysis of patients......
Subject: Pharmacogenetics
Price: $3.00
*
Study data from University of Tennessee, College of Veterinary Medicine provide new insights into colon cancer
2008 MAY 19 -- New research, 'Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells,' is the subject of a report. According to a study from the United States, "The peroxisome proliferator-activated......
Subject: Colon Cancer
Price: $3.00
*
Study findings from Vanderbilt University provide new insights into life sciences
2008 JUN 23 -- "Purpose of review The thiazolidinediones are agonists for peroxisome proliferator-activated receptor-gamma, and promote insulin sensitization and improve dyslipidemia in patients with type II diabetes mellitus. Peroxisome proliferator-activated......
Subject: Life Sciences
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login